{"id":"W4398141543","doi":"10.1007/s10637-024-01444-0","title":"Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","year":2024,"lang":"en","type":"erratum","venue":"Investigational New Drugs","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Antagonist; Internal medicine; Oncology; Immunotherapy; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006510543,0.001821394,0.002649094,0.001677794,0.00117285,0.003185291,0.002270755,0.004788504,0.0514805],"category_scores_gemma":[0.03792576,0.0008800342,0.002496577,0.001277721,0.001095285,0.001137141,0.0008577282,0.008321959,0.01412251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003524318,"about_ca_system_score_gemma":0.005593215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007379456,"about_ca_topic_score_gemma":0.0120784,"domain_scores_codex":[0.9965389,0.0009903441,0.0005544777,0.0003774924,0.001206423,0.0003324784],"domain_scores_gemma":[0.9854624,0.005645937,0.001214875,0.0005872083,0.005778659,0.001310932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004608476,0.00001183228,0.00005722242,0.0004155881,0.00007115363,0.00007778457,0.000004541183,0.00003443161,0.00004234736,0.0002296436,0.9933972,0.005197383],"study_design_scores_gemma":[0.005312741,0.00020446,0.001401854,0.001770312,0.0008312336,0.0004277783,0.00003365469,0.0004288367,0.0005081968,0.001363985,0.9876621,0.00005478033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0002519032,0.004338399,0.0005045095,0.07989611,0.9088031,0.0001730914,0.002648977,0.0001676757,0.003216255],"genre_scores_gemma":[0.01296903,0.01634505,0.004784416,0.3128286,0.5087048,0.001085104,0.004900571,0.001060234,0.1373221],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.0514805,"threshold_uncertainty_score":0.1722195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01090860077150055,"score_gpt":0.3068487250344997,"score_spread":0.2959401242629991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}